Genmab A (GMAB) EPS (Basic) (2018 - 2026)

Genmab A's (GMAB) quarterly EPS (Basic) came in at $87.79 in Q1 2026, up 9.64% YoY from $80.07 in Q1 2025, and up 0.96% on a QoQ basis from $86.95 in Q3 2025.

Genmab A (GMAB) EPS (Basic) (2018 - 2026) Analysis & Trends

Genmab A (GMAB) has 6 years of EPS (Basic) data on file, last reported at $87.79 in Q1 2026.

  • Quarterly EPS (Basic) rose 9.64% year-over-year to $87.79 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.85 (up 16.65% YoY) and the FY2025 annual result came in at $14.88, down 80.84% from the prior year.
  • EPS (Basic) rose to $87.79 in Q1 2026, from $86.95 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $87.79 in Q1 2026 to a low of -$0.04 in Q4 2024.
  • A 3-year average of $51.6 and a median of $71.99 in 2024 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2025 — EPS (Basic) soared 34.2% — and 2026, when it increased 9.64%.
  • Tracing GMAB's EPS (Basic) over 3 years: stood at -$0.04 in 2024, then surged by 197728.87% to $86.95 in 2025, then climbed by 0.96% to $87.79 in 2026.
  • The last three EPS (Basic) figures came in at $87.79 (Q1 2026), $86.95 (Q3 2025), and $8.03 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Genmab A 2.05 Bn 548.77 Mn 1.07 Bn 4.68

Historic Data

Download Data
DateValue
Jun 30, 2026 4.68
Mar 31, 2026 87.79
Sep 30, 2025 86.95
Jun 30, 2025 8.03
Mar 31, 2025 80.07
Dec 31, 2024 -0.04
Sep 30, 2024 72.60
Jun 30, 2024 5.98
Mar 31, 2024 71.38
Sep 30, 2020 0.00
Dec 31, 2019 0.00
Sep 30, 2019 11.39
Dec 31, 2018 0.00